Skip to main content
. 2021 Feb 24;18(5):2242. doi: 10.3390/ijerph18052242

Figure 3.

Figure 3

Individual and mean changes in circulating levels of (a) fibroblast growth factor 21 (FGF 21), (b) growth differentiation factor 15 (GDF15), and (c) angiopoietin-like 6 (ANGPTL6) elicited by a 12-week exercise training in metabolic syndrome patients. Circles and bars represent individual data and the means, respectively. p-values were determined by Wilcoxon signed-rank test (for FGF21 and ANGPTL6) or Student’s paired t-test (for GDF15). N.S., not statistically significant.